{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:02:06Z","timestamp":1789790526542,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2024157"],"award-info":[{"award-number":["A2024157"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515120087"],"award-info":[{"award-number":["2022B1515120087"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["SKLTCM202601"],"award-info":[{"award-number":["SKLTCM202601"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.drup.2026.101466","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:11:17Z","timestamp":1785510677000},"page":"101466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK\/T cell lymphoma"],"prefix":"10.1016","volume":"89","author":[{"given":"Cailu","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101466_bib1","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1073\/pnas.1509193112","article-title":"Transcriptional modulator ZBED6 affects cell cycle and growth of human colorectal cancer cells","volume":"112","author":"Akhtar Ali","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101466_bib2","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41590-020-0801-7","article-title":"PD-1(+) T(reg) cells: a foe in cancer immunotherapy?","volume":"21","author":"Aksoylar","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2026.101466_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1158\/0008-5472.CAN-24-1875","article-title":"Adenosine uptake through the nucleoside transporter ENT1 suppresses antitumor immunity and T-cell pyrimidine synthesis","volume":"85","author":"Allard","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib4","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101466_bib5","first-page":"735","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"Baldwin","year":"2003","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.drup.2026.101466_bib6","first-page":"2365","article-title":"Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase","volume":"60","author":"Banerjee","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1881268","article-title":"An experimental model of anti-PD-1 resistance exhibits activation of TGFss and Notch pathways and is sensitive to local mRNA immunotherapy","volume":"10","author":"Bernardo","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.drup.2026.101466_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217602","article-title":"Interleukin-2-inducible T-cell kinase inhibition to block NF-kappaB signaling exerts anti-tumor effects and enhances chemotherapy in NK\/T-cell lymphoma","volume":"618","author":"Cao","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101466_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.it.2018.07.001","article-title":"Humanized mice for the study of immuno-oncology","volume":"39","author":"De La Rochere","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.drup.2026.101466_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/2326-6066.CIR-21-0802","article-title":"Vivo syngeneic tumor models with acquired resistance to anti-PD-1\/PD-L1 therapies","volume":"10","author":"Denis","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.drup.2026.101466_bib11","article-title":"Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy","volume":"13","author":"Denis","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101466_bib12","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1158\/0008-5472.CAN-20-1259","article-title":"SUMOylation of E2F1 regulates expression of EZH2","volume":"80","author":"Du","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib13","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.R400007200","article-title":"Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway","volume":"279","author":"Evans","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101466_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.32604\/or.2024.057065","article-title":"Comparison of pegaspargase with concurrent radiation vs. P-GEMOX with sequential radiation in early-stage NK\/T-cell lymphoma","volume":"33","author":"Feng","year":"2025","journal-title":"Oncol. Res."},{"key":"10.1016\/j.drup.2026.101466_bib15","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/sj.emboj.7600134","article-title":"Combinatorial gene control involving E2F and E Box family members","volume":"23","author":"Giangrande","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2026.101466_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111004","article-title":"Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer","volume":"395","author":"Hsieh","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.drup.2026.101466_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/age.12265","article-title":"Evaluation of the causality of the zinc finger BED-type containing 6 gene (ZBED6) for six important growth traits in Nanyang beef cattle","volume":"46","author":"Huang","year":"2015","journal-title":"Anim. Genet."},{"key":"10.1016\/j.drup.2026.101466_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.drup.2026.101466_bib19","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1080\/10428190310001623801","article-title":"Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma","volume":"44","author":"Jarrett","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drup.2026.101466_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12929-016-0269-9","article-title":"Zinc finger proteins in cancer progression","volume":"23","author":"Jen","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drup.2026.101466_bib21","article-title":"ZBED6 modulates the transcription of myogenic genes in mouse myoblast cells","volume":"9","author":"Jiang","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.drup.2026.101466_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V62.4.709.709","article-title":"Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications","volume":"62","author":"Koeffler","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101466_bib23","first-page":"5443","article-title":"Characteristics of the immune microenvironment associated with RRM2 expression and its application to PD-L1\/PD-1 inhibitors in lung adenocarcinoma","volume":"13","author":"Lee","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib24","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/1078-0432.CCR-14-2680","article-title":"Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217197","article-title":"YBX1 as a therapeutic target to suppress the LRP1-beta-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer","volume":"602","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101466_bib26","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.2147\/IJGM.S366335","article-title":"A novel lncRNA panel for risk stratification and immune landscape in breast cancer patients","volume":"15","author":"Li","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.drup.2026.101466_bib27","article-title":"Identification of diagnostic markers and molecular clusters of cuproptosis-related genes in alcohol-related liver disease based on machine learning and experimental validation","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.drup.2026.101466_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-024-07163-x","article-title":"KHDRBS1 regulates the pentose phosphate pathway and malignancy of GBM through SNORD51-mediated polyadenylation of ZBED6 pre-mRNA","volume":"15","author":"Liu","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101466_bib29","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41588-023-01339-5","article-title":"Thymidinenucleotidemetabolismcontrolshuman telomerelength","volume":"55","author":"Mannherz","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drup.2026.101466_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000256","article-title":"ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth","volume":"7","author":"Markljung","year":"2009","journal-title":"PLOS Biol."},{"key":"10.1016\/j.drup.2026.101466_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2026.101466_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell. Res."},{"key":"10.1016\/j.drup.2026.101466_bib33","doi-asserted-by":"crossref","first-page":"22928","DOI":"10.1074\/jbc.M303109200","article-title":"Identification of a human homologue of the DREF transcription factor with a potential role in regulation of the histone H1 gene","volume":"278","author":"Ohshima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101466_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.21.01845","article-title":"Managing resistance to immune checkpoint inhibitors in lung cancer: treatment and novel strategies","volume":"40","author":"Passaro","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101466_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2025.107909","article-title":"Exploring the pathogenesis of extranodal natural killer\/T cell lymphoma complicated With EBV via microarray data analysis","volume":"156","author":"Peng","year":"2025","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drup.2026.101466_bib36","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s43018-020-0050-6","article-title":"Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes","volume":"1","author":"Pleasance","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2026.101466_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144269","article-title":"Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: a potential biomarker for hepatocellular carcinoma","volume":"13","author":"Qin","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2026.101466_bib38","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1038\/ncomms13398","article-title":"BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity","volume":"7","author":"Rasmussen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101466_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2025.09.003","article-title":"Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses","author":"Ren","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drup.2026.101466_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013413","article-title":"Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: a case report","volume":"97","author":"Ren","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.drup.2026.101466_bib41","first-page":"2740","article-title":"Genotoxic stress and nucleoside transport","volume":"68","author":"Repalli","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt.2858","article-title":"Development and function of human innate immune cells in a humanized mouse model","volume":"32","author":"Rongvaux","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drup.2026.101466_bib43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41590-025-02153-3","article-title":"Inhibition of ENT1 relieves intracellular adenosine-mediated T\u2009cell suppression in cancer","volume":"26","author":"Sanders","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.drup.2026.101466_bib44","first-page":"6758","article-title":"Reversal of enzymic phenotype of thymidine metabolism in induced differentiation of U-937 cells","volume":"49","author":"Shiotani","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.02.005","article-title":"A non-proliferative role of pyrimidine metabolism in cancer","volume":"35","author":"Siddiqui","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.drup.2026.101466_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102261","article-title":"Diverse strategies adopted by nature for regulating purine biosynthesis via fine-tuning of purine metabolic enzymes","volume":"73","author":"Singh","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.drup.2026.101466_bib47","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41416-019-0538-y","article-title":"EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness","volume":"121","author":"Tabbal","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101466_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101237","article-title":"CD105 blockade restores osimertinib sensitivity in drug-resistant EGFR-mutant non-small cell lung cancer","volume":"81","author":"Thiruvalluvan","year":"2025","journal-title":"Drug. Resist. Updat."},{"key":"10.1016\/j.drup.2026.101466_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-023-01483-9","article-title":"Novel target and treatment agents for natural killer\/T-cell lymphoma","volume":"16","author":"Tian","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101466_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-017-0619-6","article-title":"Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2","volume":"16","author":"Tu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101466_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009862","article-title":"Porcine ZBED6 regulates growth of skeletal muscle and internal organs via multiple targets","volume":"17","author":"Wang","year":"2021","journal-title":"PLOS Genet."},{"key":"10.1016\/j.drup.2026.101466_bib52","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1016\/j.ijrobp.2025.06.1231","article-title":"Hypoxanthine enforces cytotoxic CD8+ T cells via purine salvage synthesis and epigenetic modification to potentiate immunotherapy","volume":"123","author":"Wang","year":"2025","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.drup.2026.101466_bib53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.817","article-title":"Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2026.101466_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.773168","article-title":"What happens to the immune microenvironment after PD-1 inhibitor therapy?","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101466_bib55","doi-asserted-by":"crossref","first-page":"15997","DOI":"10.1073\/pnas.1303625110","article-title":"Transcription factor ZBED6 affects gene expression, proliferation, and cell death in pancreatic beta cells","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101466_bib56","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1007\/s00125-021-05517-0","article-title":"ZBED6 counteracts high-fat diet-induced glucose intolerance by maintaining beta cell area and reducing excess mitochondrial activation","volume":"64","author":"Wang","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.drup.2026.101466_bib57","doi-asserted-by":"crossref","first-page":"360","DOI":"10.31083\/j.fbl2910360","article-title":"Study of the role ofE2F1 and TMEM132A in prostate cancer development","volume":"29","author":"Wang","year":"2024","journal-title":"Front. Biosci. (Landmark Ed. )"},{"key":"10.1016\/j.drup.2026.101466_bib58","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/bloodadvances.2023011131","article-title":"Reprogrammingofpyrimidine nucleotide metabolismsupportsvigorouscellproliferationofnormalandmalignantT cells.","volume":"8","author":"Watanabe","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.drup.2026.101466_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/pore.2025.1612229","article-title":"Synergistic changes in bystander CD8 and conventional CD4 T cells during neoadjuvant chemoimmunotherapy for non-small cell lung cancer reveal treatment response","volume":"31","author":"Wu","year":"2025","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.drup.2026.101466_bib60","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1158\/0008-5472.CAN-16-1306","article-title":"Histone H3K27 trimethylation modulates 5-fluorouracil resistance by inhibiting PU.1 binding to the DPYD promoter","volume":"76","author":"Wu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-017-0579-0","article-title":"Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)","volume":"36","author":"Xia","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101466_bib62","article-title":"RRM2 regulates sensitivity to sunitinib and PD-1 blockade in renal cancer by stabilizing ANXA1 and activating the AKT pathway","volume":"8","author":"Xiong","year":"2021","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2026.101466_bib63","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101466_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120369","article-title":"Early diagnosis of the Need for surgical drainage in chronic pancreatitis patients based on serum metabolomics","volume":"576","author":"Xu","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.drup.2026.101466_bib65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2016-01-690701","article-title":"EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer\/T-cell lymphoma","volume":"128","author":"Yan","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101466_bib66","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2012-08-450494","article-title":"EZH2 overexpression in natural killer\/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity","volume":"121","author":"Yan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101466_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218060","article-title":"Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapy","volume":"634","author":"Yin","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101466_bib68","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1096\/fj.201901321R","article-title":"The importance of the ZBED6-IGF2 axis for metabolic regulation in mouse myoblast cells","volume":"34","author":"Younis","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2026.101466_bib69","doi-asserted-by":"crossref","first-page":"E2048","DOI":"10.1073\/pnas.1719278115","article-title":"The ZBED6-IGF2 axis has a major effect on growth of skeletal muscle and internal organs in placental mammals","volume":"115","author":"Younis","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101466_bib70","article-title":"Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101466_bib71","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1158\/1535-7163.MCT-21-0203","article-title":"SAGE1: a potential target antigen for lung cancer T-cell immunotherapy","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101466_bib72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2018.06.054","article-title":"Antigen-presenting cell-intrinsic PD-1 neutralizes PD-L1 in cis to attenuate PD-1 signaling in T cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101466_bib73","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00018-025-05891-7","article-title":"Reduced ALDH1A1 expression in multiple myeloma cells increases resistance to daratumumab via downregulation of retinoic acid","volume":"82","author":"Zheng","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drup.2026.101466_bib74","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.2021013579","article-title":"ORP4L is a prerequisite for the induction of T-cell leukemogenesis associated with human T-cell leukemia virus 1","volume":"139","author":"Zhong","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101466_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104060","article-title":"Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway","volume":"80","author":"Zhu","year":"2022","journal-title":"EBioMedicine"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626001172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:11:48Z","timestamp":1789787508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"alternative-id":["S1368764626001172"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101466","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK\/T cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101466"}}